Related Experiment Video
Updated: Jul 17, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
[Treatment trial methodology in internal medicine]
Isabelle Mahé1, Antoine Bosquet, Pablo Bartolucci
1Service de Médecine A, Hôpital Lariboisière, AP-HP, Paris. isabelle.mahe@lmr.aphp.fr
Presse Medicale (Paris, France : 1983)
|February 9, 2007
Summary
This article reviews essential clinical trial rules for valid and reliable therapeutic evaluation. It emphasizes improving internal medicine department participation in rigorous prospective randomized double-blinded clinical trials, even for complex cases.
Area of Science:
- Clinical research methodology
- Internal medicine
- Therapeutic evaluation
Context:
- Clinical trials are crucial for evaluating new treatments.
- Internal medicine departments manage diverse patient populations, complicating trial organization.
- Adherence to methodological standards ensures trial validity and reliability.
Purpose:
- To review essential clinical trial rules for validity and reliability.
- To highlight the prospective randomized double-blinded clinical trial as the gold standard.
- To explore strategies for enhancing internal medicine participation in clinical trials.
Summary:
- This review details the methodological rules critical for robust clinical trials.
- It underscores the prospective randomized double-blinded design as the most rigorous approach.
- The article addresses challenges in conducting trials within internal medicine and proposes solutions.
Impact:
- Ensures accurate therapeutic evaluation through methodologically sound clinical trials.
- Promotes the adoption of rigorous trial designs, including for rare or complex diseases.
- Aims to increase the involvement of internal medicine departments in advancing medical knowledge.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:16Crossover Experiments
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...